3-Methoxy-5-(5-methyl-tetrazol-1-yl)-phenylamine, 95.0%, 1g

Tert-butyl1,5-dimethyl-3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate, 98%, 100mg

5-Methyl-2-pyridin-4-yl-thiazol-4-ol, 95.0%, 5g

tert-Butyl ((S)-1-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)carbamate, 98%, 5g

(2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-N-(2-(2-(4-formylphenoxy)ethoxy)-4-(4-methylthiazol-5-yl)benzyl)-4-hydroxypyrrolidine-2-carboxamide, 97%, 250mg

1-Ethyl-3-methylpyridinium Bis(trifluoromethanesulfonyl)imide>98.0%(HPLC)(T)5g

Di-(4-chlorobenzyl)azodicarboxylate, 99.0%, 1g

2-Fluoro-4-hydroxybenzonitrile>98.0%(GC)(T)5g

(S)-2-Methylbutanoic acid, 95.0%, 10g

tert-Butyl (6-azaspiro[2.5]octan-1-yl)carbamate hydrochloride, 97%, 100mg

Methyl 4-(difluoromethoxy)-3-hydroxybenzoate, 97%, 250mg

1-Methyl-3-nitro-1H-pyrazole-4-carboxylic acid, 1g

Ponceau solution 0.1% in 5% acetic acid, 500g